Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives $163.21 Average Price Target from Brokerages
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong […]
More Stories
Jamf Holding Corp. (NASDAQ:JAMF) Given Average Recommendation of “N/A” by Analysts
Jamf Holding Corp. (NASDAQ:JAMF – Get Free Report) has received an average rating of “N/A” from the zero ratings firms...
Gladstone Commercial Co. (NASDAQ:GOODO) Plans $0.13 Monthly Dividend
Gladstone Commercial Co. (NASDAQ:GOODO – Get Free Report) announced a monthly dividend on Friday, October 11th, Wall Street Journal reports....
Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE:KYN) Announces Monthly Dividend of $0.08
Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE:KYN – Get Free Report) announced a monthly dividend on Friday, October 11th, Wall...
Westpac Banking Co. Plans Interim Dividend of $1.33 (ASX:WBCPH)
Westpac Banking Co. (ASX:WBCPH – Get Free Report) announced a interim dividend on Friday, October 11th, MarketIndexAU reports. Stockholders of...
Gladstone Land Co. Announces Monthly Dividend of $0.13 (NASDAQ:LANDP)
Gladstone Land Co. (NASDAQ:LANDP – Get Free Report) announced a monthly dividend on Friday, October 11th, Wall Street Journal reports....
Brokerages Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) Target Price at $18.89
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been given an average recommendation of “Moderate Buy”...